BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 28126439)

  • 21. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
    Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK
    Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shrivastava SK; Sinha SK; Srivastava P; Tripathi PN; Sharma P; Tripathi MK; Tripathi A; Choubey PK; Waiker DK; Aggarwal LM; Dixit M; Kheruka SC; Gambhir S; Shankar S; Srivastava RK
    Bioorg Chem; 2019 Feb; 82():211-223. PubMed ID: 30326403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
    Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization, SAR, antioxidant, anti-acetylcholinesterase and anti-butyrylcholinesterase activities of cephradine Schiff bases.
    Quratulain -; Abbas Khan M; Ahmad I; Hamad A; Ashraf M; Hussain S
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1989-1994. PubMed ID: 34836871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
    Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors.
    Yurttaş L; Kaplancıklı ZA; Özkay Y
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1040-7. PubMed ID: 22871134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterisation, biological evaluation and
    Durgun M; Türkeş C; Işık M; Demir Y; Saklı A; Kuru A; Güzel A; Beydemir Ş; Akocak S; Osman SM; AlOthman Z; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):950-962. PubMed ID: 32249705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antioxidant bromophenols with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions.
    Öztaskın N; Taslimi P; Maraş A; Gülcin İ; Göksu S
    Bioorg Chem; 2017 Oct; 74():104-114. PubMed ID: 28772158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular docking studies.
    Bursal E; Turkan F; Buldurun K; Turan N; Aras A; Çolak N; Murahari M; Yergeri MC
    Biometals; 2021 Apr; 34(2):393-406. PubMed ID: 33528765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Synthesis and Discovery of Schiff Bases as Potent Cholinesterase Inhibitors.
    Razik BM; Osman H; Ezzat MO; Basiri A; Salhin A; Kia Y; Murugaiyah V
    Med Chem; 2016; 12(6):527-36. PubMed ID: 26833077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
    Yan J; Sun L; Wu G; Yi P; Yang F; Zhou L; Zhang X; Li Z; Yang X; Luo H; Qiu M
    Bioorg Med Chem; 2009 Oct; 17(19):6937-41. PubMed ID: 19726199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.
    Singla S; Piplani P
    Bioorg Med Chem; 2016 Oct; 24(19):4587-4599. PubMed ID: 27519464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.